V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20223754 | 20084767 | 1.77 | 60.8 | Curative (C) | 2018-10-17 | 2018-11-01 | Enzalutamide | null | Y | OCTREOTIDE | 100121664 |
| 20223756 | 20084768 | 1.82 | 76.6 | Palliative (P) | 2019-07-25 | 2019-07-26 | CAPECITABINE + CISPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 101338876 |
| 20223759 | 20084769 | 1.6 | null | null | 2019-06-12 | 2019-06-26 | Enzalutamide | 02 | null | ENZALUTAMIDE | 100868269 |
| 20223760 | 20084770 | 1.62 | 68 | null | 2019-05-27 | 2019-06-03 | Capecitabine + Cisplatin + RT | 02 | N | CARBOPLATIN | 101640083 |
| 20223780 | 20084771 | 1.61 | 75 | Palliative (P) | 2017-07-18 | 2017-08-08 | Carboplatin AUC 2 - 5 | 02 | N | SCALOP-2 TRIAL | 100890839 |
| 20223782 | 20084772 | 0 | 0 | Palliative (P) | 2019-05-23 | 2019-05-30 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 101314256 |
| 20223784 | 20084773 | 1.76 | 99 | Palliative (P) | 2016-07-19 | 2016-08-12 | Enzalutamide | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100755959 |
| 20223791 | 20084774 | 1.69 | 40.7 | Palliative (P) | 2019-11-05 | 2019-11-19 | Enzalutamide | N | N | CETUXIMAB + OXALIPLATIN + MDG | 100847401 |
| 20223792 | 20084775 | 1.69 | 51.6 | Palliative (P) | 2016-12-06 | 2016-12-06 | Cetuximab 14 day | 02 | N | CARBOPLATIN | 101826891 |
| 20223796 | 20084776 | 1.85 | 61.2 | Palliative (P) | 2019-04-03 | 2019-04-11 | Enzalutamide | N | N | CARBOPLATIN | 101850317 |
| 20223802 | 20084777 | 1.6 | 169.3 | null | 2018-06-02 | 2018-06-08 | GemCarbo Days 1+8 | 02 | null | CARBOPLATIN + GEMCITABINE | 100787158 |
| 20223806 | 20084778 | 1.72 | 101.6 | Palliative (P) | 2018-10-11 | 2018-10-11 | Capecitabine + Cisplatin + RT | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100931357 |
| 20223811 | 20084779 | null | 81.4 | Palliative (P) | 2018-06-15 | 2018-06-15 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101548302 |
| 20223814 | 20084780 | 1.74 | 86 | Palliative (P) | 2015-07-30 | 2015-08-26 | ECF | 02 | N | CETUXIMAB | 100107787 |
| 20223820 | 20084781 | 1.59 | 80.7 | Neo-adjuvant (N) | 2018-08-26 | 2018-09-22 | Enzalutamide | 02 | N | OCTREOTIDE | 100660849 |
| 20223824 | 20084782 | 1.69 | null | Palliative (P) | 2017-12-23 | 2017-12-30 | Enzalutamide | 02 | N | ENZALUTAMIDE | 101654724 |
| 20223829 | 20084783 | 1.6 | 78.5 | Palliative (P) | 2016-10-09 | 2016-11-09 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 101236941 |
| 20223833 | 20084784 | 1.9 | 79 | Neo-adjuvant (N) | 2019-05-05 | 2019-05-05 | Enzalutamide | 02 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101766601 |
| 20223834 | 20084785 | 1.69 | 45.5 | Curative (C) | 2018-08-28 | 2018-08-30 | Enzalutamide | 02 | N | CETUXIMAB | 100496354 |
| 20223838 | 20084786 | 1.7 | 65.2 | Neo-adjuvant (N) | 2016-05-22 | 2016-05-29 | Enzalutamide | 2 | N | CETUXIMAB + OXALIPLATIN + MDG | 100443026 |
| 20223843 | 20084787 | 1.61 | 104.9 | Palliative (P) | 2018-12-05 | 2018-12-05 | Enzalutamide | null | N | OCTREOTIDE | 100008778 |
| 20223844 | 20084788 | 1.76 | 80 | Palliative (P) | 2018-12-21 | 2018-12-21 | Capecitabine + Cisplatin + RT | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100109952 |
| 20223846 | 20084789 | 1.85 | 53 | Palliative (P) | 2018-03-24 | 2018-03-26 | Enzalutamide | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100981897 |
| 20223847 | 20084790 | 1.73 | null | Adjuvant (A) | 2017-03-22 | 2017-04-25 | LUTETIUM-177 | 02 | Y | LUTETIUM-177 | 101777237 |
| 20223848 | 20084791 | 1.7 | 95 | Curative (C) | 2018-01-19 | 2018-01-29 | Enzalutamide | 02 | N | ENZALUTAMIDE | 100540643 |
| 20223849 | 20084792 | 1.7 | 61.6 | Neo-adjuvant (N) | 2019-02-07 | 2019-02-07 | Enzalutamide | 02 | null | OXALIPLATIN + RALTITREXED | 101439074 |
| 20223850 | 20084793 | null | null | Palliative (P) | 2016-12-04 | 2016-12-04 | OXALIPLATIN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100957628 |
| 20223852 | 20084794 | 1.74 | 80 | Palliative (P) | 2018-10-01 | 2018-10-02 | Enzalutamide | null | N | CISPLATIN | 100782931 |
| 20223855 | 20084795 | 1.62 | 57.2 | Curative (C) | 2016-03-17 | 2016-03-31 | ECF | 02 | N | ECF | 100173574 |
| 20223866 | 20084796 | 1.53 | 67.4 | 03 | 2016-03-06 | 2016-03-06 | Enzalutamide | 02 | N | TRASTUZUMAB | 101049432 |
| 20223869 | 20084797 | 1.68 | 64.1 | null | 2018-04-27 | 2018-04-28 | Enzalutamide | N | null | CARBOPLATIN + PACLITAXEL + RT | 101627380 |
| 20223875 | 20084798 | 1.57 | 49.7 | Palliative (P) | 2020-07-25 | 2020-07-25 | ATEZOLIZUMAB + BEVACIZUMAB | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 100452236 |
| 20223882 | 20084799 | 1.59 | 128.6 | Palliative (P) | 2018-11-29 | 2018-11-29 | Oxaliplatin + Raltitrexed | N | N | OXALIPLATIN + RALTITREXED | 101163528 |
| 20223889 | 20084800 | 164.3 | 72.3 | Adjuvant (A) | null | 2015-09-11 | Enzalutamide | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101481730 |
| 20223891 | 20084801 | 0 | 0 | Curative (C) | 2018-09-04 | 2018-10-03 | Enzalutamide | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 101168047 |
| 20223892 | 20084802 | 1.47 | 85.1 | Curative (C) | 2016-10-12 | 2016-10-12 | Enzalutamide | 02 | Y | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 100778295 |
| 20223893 | 20084803 | 1.81 | 66 | Neo-adjuvant (N) | 2016-12-22 | 2016-12-30 | CAPECITABINE + TEMOZOLOMIDE | 02 | N | CAPECITABINE + TEMOZOLOMIDE | 100479258 |
| 20223894 | 20084804 | 1.61 | 61.7 | Palliative (P) | 2018-03-01 | 2018-03-01 | Enzalutamide | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100581871 |
| 20223895 | 20084805 | 1.5 | 57.4 | Palliative (P) | 2016-08-31 | 2016-08-31 | Enzalutamide | 02 | N | CETUXIMAB + OXALIPLATIN + MDG | 101583302 |
| 20223897 | 20084806 | 1.76 | 63.5 | null | 2018-01-15 | 2018-01-17 | Oxaliplatin + Raltitrexed | N | N | OXALIPLATIN + RALTITREXED | 101078456 |
| 20223899 | 20084807 | 1.7 | 635 | Palliative (P) | null | 2019-05-24 | ECF | 02 | N | CARBOPLATIN + GEMCITABINE | 101350599 |
| 20223900 | 20084808 | 0 | 0 | Neo-adjuvant (N) | 2018-02-05 | 2018-02-25 | Oxaliplatin + Raltitrexed | 02 | N | OXALIPLATIN + RALTITREXED | 100322606 |
| 20223910 | 20084809 | 1.79 | 75 | null | 2017-01-05 | 2017-01-05 | Enzalutamide | 02 | N | TRASTUZUMAB | 101569483 |
| 20223912 | 20084810 | 1.78 | null | Curative (C) | null | 2018-03-22 | Mitomycin Intravesical | 02 | Y | MITOMYCIN INTRAVESICULAR | 100872616 |
| 20223914 | 20084811 | 1.59 | 82.5 | Palliative (P) | 2017-03-10 | 2019-07-16 | Enzalutamide | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100090701 |
| 20223919 | 20084812 | 1.62 | 76.4 | null | 2019-08-24 | 2019-08-30 | CARBOPLATIN + PACLITAXEL + RT | 02 | null | CARBOPLATIN + PACLITAXEL + RT | 100668178 |
| 20223922 | 20084813 | null | 113 | Palliative (P) | 2019-01-31 | 2019-02-09 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100486235 |
| 20223927 | 20084814 | 1.74 | 52.1 | Neo-adjuvant (N) | 2018-10-23 | 2018-10-25 | Enzalutamide | 02 | Y | ENZALUTAMIDE | 101522593 |
| 20223931 | 20084815 | null | 53 | Palliative (P) | 2019-11-11 | 2019-11-17 | Enzalutamide | 02 | N | ECF | 101220460 |
| 20223933 | 20084816 | 1.69 | 71 | Palliative (P) | 2018-07-05 | 2018-07-13 | LUTETIUM-177 | 02 | N | LUTETIUM-177 | 100904650 |